JAFRON BIOMEDICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.68 CNY | +1.30% |
|
+0.92% | +33.51% |
| Apr. 26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
| Apr. 25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.
Calendar
2024-05-20
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.68
CNY
Average target price
30.94
CNY
Spread / Average Target
+4.26%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +33.51% | 3.14B | |
| -4.82% | 182B | |
| +1.38% | 110B | |
| -2.82% | 68.11B | |
| +0.69% | 50.53B | |
| +8.54% | 44.8B | |
| +2.58% | 40.7B | |
| +20.50% | 32.25B | |
| +1.72% | 26.53B | |
| +14.69% | 25.02B |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Jafron Biomedical : to Issue $155 Million Convertible Renminbi Bonds